Menu Search
Equities

Huron Consulting Group Inc

HUR:BRN

Huron Consulting Group Inc

Actions
  • Price (CHF)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Huron Consulting Group Inc. is a professional services company. The Company operates in three segments: Healthcare, Education, and Commercial. The Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups; payors; and long-term care or post-acute providers. The Education segment serves public and private colleges and universities, research institutes and other education-related organizations. The Commercial segment is focused on serving industries and organizations facing disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. It also engaged in offering advisory services and strategic support for philanthropy strategies and campaigns, serving the educational, healthcare, and nonprofit landscape.

  • Revenue in USD (TTM)1.47bn
  • Net income in USD85.47m
  • Incorporated2002
  • Employees6.48k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		HURN:NSQ since
announced		Transaction
value
Grenzebach Glier & Associates IncDeal completed12 Feb 202412 Feb 2024Deal completed24.41%--
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.